Table of Contents: How much weight can I lose in a month on semaglutide GLP-1
Oral metabolic franchise, a broader portfolio of oral small molecule candidates targeting metabolic disease beyond the lead GLP-1 program Recent Highlights: In May 2026, Structure reported positive end-of-Phase 2 feedback from the FDA for aleniglipron, clearing the way to begin a Phase 3 registrational program for chronic weight management in Q3 2026
Horowitz, MD, Rheumatology and Internal Medicine, Northwell Health, Great Neck, NY
Weight loss in non diabetic patients is not as well documented at the 14 mg maximum dose
This benefit can help users push through challenging workouts and achieve their desired results
In terms of appeal, almost half of US GLP-1 users (45%) express some switching preference: for lighter or better-for-you versions of beer and wine, for zero- or low-alcohol versions of their favourites, or for premium quality versions of their favourite drinks now that less is more. Callum Saunders, planning director at brand activation agency Zeal, which works with global brands including Nestl, Carlsberg, and Britvic, is equally upbeat